1. Intracellular rod-like crystals in chronic lymphocyte leukemia

   • Yiling Huang
   • Lixia Zhang

   Images in Hematology 14 July 2020 Pages: 267 - 267

   

2. JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN)

   • Kazuya Shimoda
   • Naoto Takahashi
   • Masahiro Kizaki

   Guideline 11 August 2020 Pages: 268 - 291

   

3. Current insights into the treatments of severe aplastic anemia in China

   • Lei Ye
   • Fengkui Zhang
   • Seiji Kojima

   Review Article 03 August 2020 Pages: 292 - 299

   

4. A high-throughput detection method for the clonality of Human T-cell leukemia virus type-1-infected cells in vivo

   • Masumichi Saito
   • Hiroo Hasegawa
   • Katsunori Yanagihara

   Rapid Communication 29 July 2020 Pages: 300 - 306

   

5. Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan

   • Toyomi Kamesaki
   • Jun-ichi Nishimura
   • Yuzuru Kanakura

   Original Article 30 June 2020 Pages: 307 - 315

   

6. Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells

   • Aya Fujishiro
   • Masaki Iwasa
   • Yasuo Miura

   Original Article 22 June 2020 Pages: 316 - 330

   

7. Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C

   • Takahiro Kaido
   • Masahiro Yoda
   • Nobuo Okumura

   Original Article 19 June 2020 Pages: 331 - 340

   

8. Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy

   • Yukiko Kawaguchi
   • Bungo Saito
   • Tsuyoshi Nakamaki

   Original Article 10 June 2020 Pages: 341 - 348

   

9. Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

   • Hideho Henzan
   • Ken Takase
   • for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

   Original Article 10 June 2020 Pages: 349 - 360

   

10. Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis

    • Alexandre Nonino
    • Paulo Vidal Campregher
    • Rinaldo Wellerson Pereira

    Original Article 13 June 2020 Pages: 361 - 368

    

11. Impact of prednisolone dosage in the CHOP regimen for follicular lymphoma: a retrospective study

    • Takashi Ikeda
    • Shin-ichiro Fujiwara
    • Yoshinobu Kanda

    Original Article 11 June 2020 Pages: 369 - 376

    

12. Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera

    • Ivan Krečak
    • Hrvoje Holik
    • Velka Gverić-Krečak

    Original Article 08 June 2020 Pages: 377 - 384

    

13. Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan

    • Yu-Hung Wang
    • Shan-Chi Yu
    • Tai-Chung Huang

    Original Article 09 June 2020 Pages: 385 - 394

    

14. Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator

    • Hisashi Takei
    • Hirofumi Fukuda
    • Susumu S. Kobayashi

    Original Article 12 June 2020 Pages: 395 - 408

    

15. Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

    • Shun-ichi Kimura
    • Hiroyuki Fujita
    • Japan Adult Leukemia Study Group (JALSG)

    Original Article 18 June 2020 Pages: 409 - 417

16. Ruxolitinib as first-line therapy in secondary hemophagocytic lymphohistiocytosis and HIV infection

    • Sergio Gálvez Acosta
    • Mariana Javalera Rincón

    Case Report 13 April 2020 Pages: 418 - 421

    

17. Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy

    • Kentaro Mizuhara
    • Nobuharu Fujii
    • Yoshinobu Maeda

    Case Report 27 April 2020 Pages: 422 - 426

    

18. Toward further simplification of elotuzumab therapy by subcutaneous administration

    • Yuji Shimura
    • Taku Tsukamoto
    • Junya Kuroda

    Letter to the Editor 13 July 2020 Pages: 427 - 428

    

19. J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors

    • Sho Okamoto
    • Hiroshi Ureshino
    • Shinya Kimura

    Letter to the Editor 12 July 2020 Pages: 429 - 430

    

20. Correction to: Measurable residual disease after the first consolidation predicts the outcomes of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

    • Hideho Henzan
    • Ken Takase
    • for the Fukuoka Blood & Marrow Transplantation Group (FBMTG)

    Correction 08 July 2020 Pages: 431 - 432